drugset / Trial / NCT04161872
Nutraceutical on Hyperuricemia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study will be to evaluate if a nutraceutical containing quercetin, rutin, bromelain and L-carnosine (Uricemin®) can reduce uric acid levels in subjects with values between ≥ 6 and \< 7 mg/dl after 3 months of therapy.
Timeline
- Start
- 2018-10-01
- Primary completion
- 2019-11-30
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Uricemin | Unknown | — | — |
Indications
No indication recorded.